Close Menu

This article has been updated from a previous version to include a statement from ERS Genomics on the EPO's decision regarding the Broad Institute's European patents.

NEW YORK (GenomeWeb) – Rockefeller University and the Broad Institute said this week that they have settled a dispute over the inventorship and ownership of certain CRISPR-Cas9 intellectual property, leaving the specifics of the IP unchanged.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.